Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 480 of 1,261
  1. US 10376574

    Compositions and methods for vaccination against influenza A virus

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  2. US 10377742

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  3. US 10376598

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  4. US 10376517

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  5. US 10377695

    Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  6. US 10377739

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  7. US 10377798

    Recombinant respiratory syncytial virus G protein fragments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  8. US 10377748

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  9. US 10377782

    Nucleotide analogs

    The Regents of the University of California · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  10. US 10376582

    Buffer formulations for enhanced antibody stability

    Outlook Therapeutics, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  11. US 10376590

    Sustained delivery formulations of risperidone compound

    Indivior UK Limited · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  12. US 10376588

    Etanercept formulations stabilized with combinations of sugars and polyols

    Coherus BioSciences, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  13. US 10376577

    Refined product obtained from rice hull and preparation process and use thereof

    China Medical University · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  14. US 10376558

    Method and compositions for synchronizing time of insemination in gilts

    United-AH II, LLC · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  15. US 10376567

    Fusion molecule based on TAA variant

    The Regents of the University of California · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  16. US 10376552

    Memory improving composition comprising arillus longan, semen nelumbinis, poria and semen juglandis

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  17. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  18. US 10376510

    2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  19. US 10376487

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  20. US 10376486

    Compositions and methods for reactivating latent viral infections

    The Regents of the University of California · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  21. US 10376489

    Wound healing

    The Regents of the University of California · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  22. US 10376495

    Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)

    The United States Government as Represented by the Department of Veterans · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  23. US 10376515

    Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7

    Northwestern University · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  24. US 10379109

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.